Moramide intermediate
Moramide intermediate (3-methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.
|  | |
| Clinical data | |
|---|---|
| Other names | moramide intermediate | 
| Routes of administration | N/A | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C21H25NO3 | 
| Molar mass | 339.435 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
In the United States, moramide intermediate is designated as a Schedule II controlled substance,[1] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[2]
See also
    
- Moramide
- Methadone intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.